Development of Membrane-Bound GM-CSF and IL-18 as an Effective Tumor Vaccine.
The development of effective adjuvant is the key factor to boost the immunogenicity of tumor cells as a tumor vaccine. In this study, we expressed membrane-bound granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-18 (IL-18) as adjuvants in tumor cells to stimulate immune respo...
Main Authors: | Chien-Chiao Huang, Kung-Kai Kuo, Ta-Chun Cheng, Chih-Hung Chuang, Chien-Han Kao, Yuan-Chin Hsieh, Kuang-Hung Cheng, Jaw-Yuan Wang, Chiu-Min Cheng, Chien-Shu Chen, Tian-Lu Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4506079?pdf=render |
Similar Items
-
Functional production of a soluble and secreted single-chain antibody by a bacterial secretion system.
by: Chiu-Min Cheng, et al.
Published: (2014-01-01) -
ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells
by: Yi-Jung Huang, et al.
Published: (2022-09-01) -
Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
by: Hillard M. Lazarus, et al.
Published: (2023-01-01) -
G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors
by: Kai He, et al.
Published: (2022-07-01) -
“Same same” but different? Exploring the impact of perceived organizational support at the school and teacher levels on teachers’ job engagement and organizational citizenship behavior
by: Chuan-Chung Hsieh, et al.
Published: (2022-12-01)